Prevalence of multidrug resistant Shigella isolated in Malaysia by Thong, Kwai Lin et al.
356          J Health Popul Nutr   Dec 2002 Thong KL et al.
J HEALTH POPUL NUTR    2002 Dec;20(4):356-358 © 2002 ICDDR,B: Centre for Health and Population Research
ISSN 1606-0997        $ 5.00+0.20
LETTER-TO-THE-EDITOR
Prevalence of Multidrug-resistant Shigella
Isolated in Malaysia
Sir,
Shigellosis, a disease caused by Shigella spp., is endemic
in Malaysia. Its low infective dose and ease of spread
through person-to-person transmission by the faecal-oral
route make this infection difficult to control in outbreak
situations. Antimicrobial therapy is recommended for
shigellosis because it can shorten the severity and
duration of illness, reduce shedding of the organism, and
prevent secondary complications and deaths. However,
due to the global emergence of drug resistance, the
choices of antimicrobial agents for empiric therapy for
shigellosis are now limited (1). Although antimicrobial
resistance of Shigella spp. is well-documented in many
countries (2-4), there is a lack of such documentation in
Malaysia. Hence, the study was undertaken to determine
the antimicrobial resistance patterns of the Malaysian
strains of Shigella spp. This study, to the best of our
knowledge, is the first report on the antimicrobial
resistance of Shigella spp. in Malaysia.
One hundred clinical strains (stools, n=98; blood,
n=2) of Shigella spp. isolated during 1997-2000 from
sporadic cases of endemic shigellosis in different parts
of Malaysia, were studied. Shigella spp. were identified
by biochemical and serological tests at the Institute for
Medical Research, Kuala Lumpur, Malaysia.
Antimicrobial susceptibility tests were determined by
the Bauer-Kirby disc-diffusion method (5). Antibiotic
disks (Oxoid, UK) of 10 antimicrobial agents: ampicillin
(Amp), amikacin (An), chloramphenicol (Chl),
ciprofloxacin (Cip), ceftriaxone (Cro), kanamycin (Kan),
streptomycin (Str), tetracycline (Tet), trimethoprim
(Tmp), and trimethoprim-sulphamethoxazole (SxT) were
tested. Zones of inhibition were recorded in millimetres
and interpreted as sensitive, intermediate, or resistant
according to the instructions of the manufacturer.
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Minimum inhibitory concentrations (MICs) of
ampicillin, chloramphenicol, streptomycin, tetracycline,
trimethoprim, and trimethoprim-sulphamethoxazole for
selected strains were determined by the agar dilution
technique according to the recommendations of the
National Committee for Clinical Laboratory Standards
[6]. Escherichia coli ATCC 25922, Escherichia coli
ATCC 29213, Staphylococcus aureus ATCC 25923, and
Pseudomonas aeruginosa ATCC 27853 were used as
quality control organisms.
Of the 100 clinical strains of Shigella tested, 88%,
11%, and 1% were Shigella flexneri, S. dysenteriae, and
S. boydii respectively. Nine serotypes—1a (n=3), 1b
(n=40), 2a (n=27), 3a (n=20), 3b (n=1), 3c (n=9), 4a
(n=10), 6 (n=1), and y (n=2)—belonged to S. flexneri.
Two serotypes of S. dysenteriae—type 2 (n=10) and 6
(n=1)—were isolated, while the only S. boydii isolate
was of serotype 6. As reported in other developing
countries, S. flexneri is also the most common species
in Malaysia (1).
Twenty-seven percent of all Shigella isolates tested
showed full sensitivity, while 73% were highly resistant
to at least one antibiotic. Overall, 72%, 57%, 56%, 55%,
41%, 34%, and 8% of Shigella spp. were resistant to
streptomycin, tetracycline, ampicillin, chloramphenicol,
trimethoprim, trimethoprim-sulphamethoxazole, and
kanamycin respectively. All the strains were susceptible
to ciprofloxacin, ceftriaxone, and amikacin, except 3
strains of S. flexneri serotype 1b, which had intermediate
susceptibility to amikacin. All the 10 S. dysenteriae
serotype 2 were resistant to streptomycin, while S.
dysenteriae serotype 6 and S. boydii strains were fully
sensitive.
Species-specific trends of drug resistance were
analyzed for S. flexneri. The resistance rates of S. flexneri
to trimethoprim and trimethoprim-sulphamethoxazole
steadily increased from 9.1% in 1997 to 64.3% in 2000.
Resistance to kanamycin was first observed in 1998
(5.7%) and then increased from 10.0% to 21.4% in 1999
and 2000 respectively. The high rate of resistance to
trimethoprim-sulphamethoxazole and trimethoprim and
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the emergence of resistance to kanamycin suggest that
the routine use of these drugs in treating patients with
suspected shigellosis should be reviewed. Resistance of
S. flexneri to ampicillin, chloramphenicol, streptomycin,
and tetracycline remained high from 1997 through 2000
with only minor fluctuations. Such high resistance rates
have been reported in Israel (2), Northeast Brazil (3),
Hong Kong (4), Egypt (7), and elsewhere (3). The
continuous overuse of these antimicrobial agents in the
treatment of shigellosis probably sustained these resistant
traits.
Multidrug resistance rates of S. flexneri were high
too, since 71.6% of the strains were resistant to at least
two antimicrobial agents. Twelve resistant phenotypes
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The MICs of selected S. flexneri strains showed a
high percentage of resistance to streptomycin (91.7%),
tetracycline (70.8%), and chloramphenicol (65.4%). The
values of MICs for ampicillin and chloramphenicol
(≥64 µg/mL and ≥128 µg/mL respectively) were similar
to those reported in Hong Kong (4). MIC
90
 for
streptomycin, trimethoprim, and trimethoprim-
sulphamethoxazole were strikingly high (≥1024 µg/mL).
The high MICs could have a profound impact on the
treatment of shigellosis because certain antimicrobial
agents, such as chloramphenicol, are toxic to human cells
at high concentrations.
Isolates of Shigella in Malaysia are still sensitive to
ciprofloxacin, ceftriaxone, and amikacin. The use of
ciprofloxacin in children is debatable. Ceftriaxone is a
good choice of drug for the treatment of shigellosis since
cephalosporins are an effective agent against Shigella
species and also safe (2). Evidence suggests that
resistance to amikacin was developing among S. flexneri
type strains in Malaysia as three strains of S. flexneri
serotype 1b showed intermediate susceptibility to
amikacin. Amikacin is a modified form of kanamycin
A, which has a substituted aminobutryl in the amino
group at position 1 in the 2-deoxystreptamine ring, and
this enhances its resistance to some types of
aminoglycoside-modifying enzymes (7). The emergence
of resistance of S. flexneri to kanamycin may suggest
the possibility of Shigella spp. in Malaysia acquiring
resistance to amikacin too. Thus, the use of amikacin in
routine treatment of shigellosis should be carried out
either in a controlled manner or in conjunction with other
antimicrobial agents to delay the development of
resistance.
Our study has shown that resistance of S. flexneri to
chloramphenicol was always linked to resistance to
ampicillin, tetracycline, and streptomycin. This
observation suggests that genes encoding the resistance
to these antimicrobial agents could be linked together
as a group or a cassette. This assumption was supported
by a study by Casalino and colleagues who showed that
genes encoding for resistance to ampicillin,
chloramphenicol, tetracycline, and spectinomycin
formed a linkage group located on the chromosome (8).
The endemicity and prevalence of high resistance
rates of Shigella spp. neccesitate better control measures,
such as improving public hygiene, preventing excessive
use of existing antimicrobial agents, or the development
of newer, more broad-spectrum antimicrobial agents.
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